BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15490314)

  • 21. Constituents in Easter lily flowers with medicinal activity.
    Francis JA; Rumbeiha W; Nair MG
    Life Sci; 2004 Dec; 76(6):671-83. PubMed ID: 15567192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-inflammatory action of legume isoflavonoid sophoricoside through inhibition on cyclooxygenase-2 activity.
    Kim BH; Chung EY; Min BK; Lee SH; Kim MK; Min KR; Kim Y
    Planta Med; 2003 May; 69(5):474-6. PubMed ID: 12802736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant, cyclooxygenase and topoisomerase inhibitory compounds from Apium graveolens Linn. seeds.
    Momin RA; Nair MG
    Phytomedicine; 2002 May; 9(4):312-8. PubMed ID: 12120812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
    Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and isolation of the cyclooxygenase-2 inhibitory principle in Isatis tinctoria.
    Danz H; Stoyanova S; Wippich P; Brattström A; Hamburger M
    Planta Med; 2001 Jul; 67(5):411-6. PubMed ID: 11488453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel cyclooxygenase-inhibitory stilbenolignan from the seeds of Aiphanes aculeata.
    Lee D; Cuendet M; Vigo JS; Graham JG; Cabieses F; Fong HH; Pezzuto JM; Kinghorn AD
    Org Lett; 2001 Jul; 3(14):2169-71. PubMed ID: 11440571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid peroxidation, cyclooxygenase enzyme and tumor cell proliferation inhibitory compounds in Cornus kousa fruits.
    Vareed SK; Schutzki RE; Nair MG
    Phytomedicine; 2007 Oct; 14(10):706-9. PubMed ID: 17084606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoperoxidation and cyclooxygenases 1 and 2 inhibitory compounds from Iryanthera juruensis.
    Silva DH; Zhang Y; Santos LA; Bolzani VS; Nair MG
    J Agric Food Chem; 2007 Apr; 55(7):2569-74. PubMed ID: 17335225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bruguiesulfurol, a new sulfur compound from Bruguiera gymnorrhiza.
    Homhual S; Zhang HJ; Bunyapraphatsara N; Kondratyuk TP; Santarsiero BD; Mesecar AD; Herunsalee A; Chaukul W; Pezzuto JM; Fong HH
    Planta Med; 2006 Feb; 72(3):255-60. PubMed ID: 16534731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of COX isoforms by nutraceuticals.
    Seaver B; Smith JR
    J Herb Pharmacother; 2004; 4(2):11-8. PubMed ID: 15364641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radical scavenging glycoprotein inhibiting cyclooxygenase-2 and thromboxane A2 synthase from aloe vera gel.
    Yagi A; Kabash A; Mizuno K; Moustafa SM; Khalifa TI; Tsuji H
    Planta Med; 2003 Mar; 69(3):269-71. PubMed ID: 12677534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase inhibitory and antioxidant compounds from crabapple fruits.
    Seeram NP; Cichewicz RH; Chandra A; Nair MG
    J Agric Food Chem; 2003 Mar; 51(7):1948-51. PubMed ID: 12643656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bases for a spinal analgesic action of cyclooxygenase inhibitors.
    Vanegas H
    Proc West Pharmacol Soc; 2002; 45():225-7. PubMed ID: 12434585
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal.
    Di Nunno L; Vitale P; Scilimati A; Tacconelli S; Patrignani P
    J Med Chem; 2004 Sep; 47(20):4881-90. PubMed ID: 15369392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and inhibitory activity against COX-2 catalyzed prostaglandin production of chrysin derivatives.
    Dao TT; Chi YS; Kim J; Kim HP; Kim S; Park H
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1165-7. PubMed ID: 14980657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of 4,5-diaryl-1H-pyrazole-3-ol derivatives as potential COX-2 inhibitors.
    Patel MV; Bell R; Majest S; Henry R; Kolasa T
    J Org Chem; 2004 Oct; 69(21):7058-65. PubMed ID: 15471453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concluding remarks. C0X-2-selective inhibition: a new advance in pain management.
    Korttila K
    Eur J Anaesthesiol Suppl; 2002; 25():21-3. PubMed ID: 12596801
    [No Abstract]   [Full Text] [Related]  

  • 38. Design of acyclic triaryl olefins: a new class of potent and selective cyclooxygenase-2 (COX-2) inhibitors.
    Uddin MJ; Rao PN; Knaus EE
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1953-6. PubMed ID: 15050635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of natural products containing acylresorcinol partial structures on cyclooxygenases and 5-lipoxygenase.
    Bracher F; Krauss J; Laufer S
    Pharmazie; 2001 May; 56(5):430. PubMed ID: 11400568
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of cyclo-oxygenase-2 expression in mouse macrophages by 4-(3-methyl-but-1-enyl)-3,5,3',4'-tetrahydroxystilbene, a resveratrol derivative from peanuts.
    Patel B; Patel S; Hoffman R
    Phytother Res; 2005 Jun; 19(6):552-5. PubMed ID: 16114095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.